GCM
MLAB icon

Gladius Capital Management’s Mesa Laboratories MLAB Stock Holding History

Gladius Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-311
Closed -$27K – 333
2024
Q2 		$27K Sell
311
-62
-17% -$6.49K ﹤0.01% 289
2024
Q1 		$40.9K Buy
+373
New +$37.6K 0.01% 205

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gladius Capital Management's MLAB Position: Q3 2024 in Review

Gladius Capital Management sold out of Mesa Laboratories (MLAB) in Q3 2024, closing a stake of 311 shares — an estimated $27K sold.

Gladius Capital Management first reported a position in MLAB in Q1 2024 and held it in 2 quarters. The position peaked at $40.9K in Q1 2024. 166 funds tracked by Wall St. Rank hold MLAB as of Q3 2024.

  • Gladius Capital Management reported no remaining Mesa Laboratories position as of Q3 2024 after selling out during the quarter.
  • Gladius Capital Management sold 311 Mesa Laboratories shares in Q3 2024, an estimated $27K.
  • Gladius Capital Management first reported a position in Mesa Laboratories in Q1 2024 and held it in 2 quarters.
  • Gladius Capital Management's Mesa Laboratories position peaked at $40.9K in Q1 2024.
  • 166 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2024.

Based on Gladius Capital Management's 13F filing for Q3 2024, filed 6 Nov 2024.